Concepedia

Radko Komers

RK

Statistics

Publications

56

Citations

3.6K

H-Index

31

Active since

1994

Affiliations

Oregon Health & Science University(Current)

Portland VA Medical Center

Institute of Clinical and Experimental Medicine

Therapeutics Clinical Research

University of Michigan

Radko Komers is an author at Oregon Health & Science University specializing in renal pathophysiology, medicine, and renal disease.

ORCID

Publications per year

1994–2024

56

Publications

56

Suppression of microRNA-29 Expression by TGF-β1 Promotes Collagen Expression and Renal Fibrosis

Bo Wang, Radko Komers, Rosemarie M. Carew et al. · Journal of the American Society of Nephrology · 2011 · 489 citations · Full text

, , +17

<i>miR-21</i> promotes renal fibrosis in diabetic nephropathy by targeting PTEN and SMAD7

Aaron McClelland, Michal Herman‐Edelstein, Radko Komers et al. · Clinical Science · 2015 · 231 citations

, , +16

Sparsentan in patients with IgA nephropathy: a prespecified interim analysis from a randomised, double-blind, active-controlled clinical trial

Hiddo J.L. Heerspink, Jai Radhakrishnan, Charles E. Alpers et al. · The Lancet · 2023 · 215 citations · Full text

, , +12

Immunohistochemical and functional correlations of renal cyclooxygenase-2 in experimental diabetes

Radko Komers, Jessie N. Lindsley, T Oyama et al. · Journal of Clinical Investigation · 2001 · 188 citations · Full text

, , +17

DUET: A Phase 2 Study Evaluating the Efficacy and Safety of Sparsentan in Patients with FSGS

Howard Trachtman, Peter J. Nelson, Sharon G. Adler et al. · Journal of the American Society of Nephrology · 2018 · 182 citations · Full text

, , +17

1–5 of 56